Natixis Tandem Diabetes Care Inc Transaction History
Natixis
- $17.6 Billion
- Q3 2024
A detailed history of Natixis transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Natixis holds 12,200 shares of TNDM stock, worth $432,978. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,200Holding current value
$432,978% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding TNDM
# of Institutions
354Shares Held
71.9MCall Options Held
3.36MPut Options Held
229K-
Black Rock Inc. New York, NY11.1MShares$395 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.36MShares$261 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA3.27MShares$116 Million0.02% of portfolio
-
State Street Corp Boston, MA2.66MShares$94.3 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.39MShares$84.7 Million1.44% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $2.28B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...